ImClone Investigational Site

Durham, North Carolina 27710

0 studies enrolling now · 4 studies all time

What they study most

Cancer, Colorectal Cancer, Colorectal Neoplasms, Metastases, Neoplasm, Prostate Cancer

Studies at this site

• A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancer — Completed
• Study of IMC-1121B in Patients With Advanced Solid Tumors Not Responding To Standard Therapy — Completed
• Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy — Completed
• Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer — Completed